FDA Says CBD Still Can’t Be Dietary Supplement

January 26, 2023 · Green Market Report

The agency called on Congress to develop a better regulatory framework for CBD

The U.S. Food and Drug Administration this week announced that it would deny a trio of petitions that requested authorization for cannabidiol (CBD) to be used as a dietary supplement. The agency also advised that Congress needs to establish a better regulatory framework before such a classification is allowed.

Based on existing research and data, the FDA found that the current standards for adding supplements to foods or beverages aren’t sufficient for cannabinoids such as CBD, Reuters reported.

“We have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm,” FDA Principal Deputy Commissioner Janet Woodcock said.

The news reinforces a situation that’s long been apparent for those in the CBD trade: Congress needs to take action before the potential of the market can be fully unleashed.

The issue has been a thorn in the side of hemp and CBD companies for years; the FDA ruled back in 2015 that CBD was not permitted to be used in foods or beverages as a supplement, and it has remained steadfast in that position ever since.

The agency has also been cracking down for years on CBD producers that make health benefit claims or other assertions about their product lines which can’t yet be backed up by solid science, or which have been marketed to kids. (Full Story)

In categories:CBD Medical
Next Post

Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin

Core One Labs' Akome Partners To Study Next-Gen Psychedelics A subsidiary of Core One Labs  CLABF has signed a contract with Fundació Bosh I Gimpera to begin second-phase studies evaluating the therapeutic potential of its bio-compounds (both alone and combined with psychedelic substances). The…
Read
Previous Post

Too good to be brew! DMT - the potent psychedelic in Ayahuasca - treats depression after a SINGLE dose, cutting-edge clinical trial shows

DMT — the most potent psychedelic known to man —  treats people with severe depression after a single dose, a cutting-edge clinical trial suggests. Up to six in ten who received a single dose of DMT intravenously before therapy were declared depression-free…
Read
Random Post

Americans Want Marijuana Less Strictly Regulated While Backing Tighter Rules On Teslas, Crypto And Twitter, Poll Finds

Americans say that marijuana should be less strictly regulated than it is now, while also favoring greater regulations on cryptocurrencies, social media, electric vehicles and coal, according to a new poll. The Harvard CAPS-Harris Poll surveyed voters about a wide…
Read
Random Post

Former Trump Drug Czar Says Top Federal Officials Stopped FDA From Scheduling Kratom Amid Concern About Agency’s ‘Bias’

As the U.S. Food and Drug Administration (FDA) under the Trump administration prepared to propose federal restrictions on kratom, a number of top officials intervened, criticizing the agency’s “bias” and stopping it “on the spot” from moving ahead with scheduling,…
Read
Random Post

Cannabis bars could debut on Long Island under new rules

Long Islanders may soon be able to share a joint with a fellow sports fan at the bar – or toke over trivia. Dozens of cannabis lounges may debut on Long Island under rules proposed by state regulators Thursday. Plans for…
Read
Random Post

You Can't Threaten to Kill Everyone and Keep Your Marijuana Dispensary License

After breaching regulations and losing some employees, the owner of an Athol dispensary threatened his former staff in a video on Instagram. In response, state officials have taken action and suspended the dispensary's license. In the video, the owner made…
Read